Please assess the completion status of the following clinical trial:

Trial Title: Intradialytic Drug Removal by Short-daily Hemodialysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* \> 18 years old~* currently receiving short-daily HD six times per week~* have no other acute intercurrent illness~Exclusion Criteria:~* history of a vancomycin, gentamicin or levofloxacin allergy~* weight within ± 30% of their ideal body weight~* Hgb \< 10 mg/dl

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intravenous antibiotics (Type: EXPERIMENTAL): Intervention: administer intravenous vancomycin, gentamicin and levofloxacin. This study will determine the pharmacokinetics of intravenous vancomycin, gentamicin and levofloxacin in subjects receiving short-daily hemodialysis. There will not be a control arm for this study. The intervention for this arm will be to administer intravenous vancomycin, gentamicin and levofloxacin and draw blood samples at periodic intervals. The blood samples will be tested for these medications and pharmacokinetic analysis will be performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).